A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.

药代动力学 医学 毒性 中性粒细胞减少症 限制 喜树碱 药理学 最大耐受剂量 入射(几何) 化疗 内科学 胃肠病学 化学 工程类 有机化学 物理 光学 机械工程
作者
Mitchell Garrison,Lisa A. Hammond,Charles E. Geyer,Garry Schwartz,Anthony W. Tolcher,Leslie Smetzer,José A. Figueroa,Murray P. Ducharme,John Coyle,Chris H. Takimoto,Robert L. De Jager,Eric K. Rowinsky
出处
期刊:PubMed 卷期号:9 (7): 2527-37 被引量:7
链接
标识
摘要

The purpose of this study was to assess the feasibility of administering exatecan, a water-soluble, potent camptothecin analogue, as a protracted 21-day continuous i.v. infusion (CIVI). The study also sought to determine the maximum tolerated dose (MTD) of exatecan on a 21-day CIVI schedule, characterize its pharmacokinetic behavior, and seek preliminary evidence of anticancer activity.Exatecan dose-schedule development was performed in two stages using the modified Continual Reassessment Method and single patient cohorts. First, patients with advanced solid malignancies were treated with exatecan (0.15 mg/m(2)/day) as a CIVI for 5 days, and the duration of the CIVI was incrementally increased from 5 to 21 days. In the second stage of the study, the dose was incrementally increased to derive a tolerable dose of exatecan administered as 21-day CIVI. The MTD was defined for both minimally pretreated (MP) and heavily pretreated (HP) patients as the highest dose level at which the incidence of dose-limiting toxicity does not exceed 20%.Thirty-one patients were treated with 100 courses of exatecan at 6 dose-schedule levels. The incidence of the principal dose-limiting toxicities, neutropenia and thrombocytopenia, was unacceptably high at exatecan doses exceeding 0.15 mg/m(2)/day as a 21-day CIVI, which was determined to be the MTD for both MP and HP patients. The pharmacokinetics of exatecan were dose-proportional, and mean [coefficient of variation (percentage) steady-state concentration (plasma concentration at steady-state)] values ranged from 6.88 (80.6) to 19.41 (74.2) ng/ml at exatecan dose levels ranging from 0.15 to 0.30 mg/m(2)/day, which are similar to IC(50) values against human tumor cell lines treated for shorter periods. Mean pharamacokinetic parameters for total exatecan derived from a compartmental model included clearance and volume of distribution values of 1.39 (86.9) liters/h/m(2) and 39.66 (197.4) liters, respectively. Two HP patients with non-small cell lung and unknown primary carcinomas had partial responses, and objective evidence of anticancer activity and clinical benefit were noted in several other individuals.The administration of exatecan as a 21-day CIVI at doses as high as 0.15 mg/m(2)/day is safe and feasible for both MP and HP patients. The characteristics of the myelosuppressive effects of exatecan on this schedule, the paucity of severe nonhematological toxicities, and documented anticancer activity in several drug-refractory malignancies warrant further evaluation of the merits of administering exatecan by either a CIVI or alternate drug delivery systems to achieve protracted systemic exposure.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
fish完成签到 ,获得积分10
1秒前
曲艺发布了新的文献求助10
2秒前
2秒前
古夕完成签到,获得积分10
3秒前
4秒前
5秒前
5秒前
7秒前
lm发布了新的文献求助10
7秒前
无所归兮应助曲艺采纳,获得10
8秒前
8秒前
yar应助alone采纳,获得30
9秒前
za==应助小赵采纳,获得10
9秒前
10秒前
豆芽发布了新的文献求助10
10秒前
oky发布了新的文献求助10
10秒前
wdy111应助迷路硬币采纳,获得20
12秒前
12秒前
13秒前
艺高人胆大鸡腿完成签到 ,获得积分10
16秒前
乐乐应助焦糖采纳,获得10
16秒前
科研通AI2S应助nalan采纳,获得10
17秒前
静_完成签到 ,获得积分10
17秒前
17秒前
雪白元蝶发布了新的文献求助10
18秒前
18秒前
18秒前
留白完成签到 ,获得积分10
19秒前
共享精神应助小圆采纳,获得10
19秒前
19秒前
慕青应助梵高的向日葵采纳,获得10
19秒前
SYLH应助科研通管家采纳,获得20
19秒前
czh应助科研通管家采纳,获得10
19秒前
19秒前
ding应助科研通管家采纳,获得10
19秒前
搜集达人应助科研通管家采纳,获得10
20秒前
打打应助科研通管家采纳,获得10
20秒前
20秒前
彭于彦祖应助科研通管家采纳,获得10
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Economic Geography and Public Policy 900
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988786
求助须知:如何正确求助?哪些是违规求助? 3531116
关于积分的说明 11252493
捐赠科研通 3269766
什么是DOI,文献DOI怎么找? 1804771
邀请新用户注册赠送积分活动 881870
科研通“疑难数据库(出版商)”最低求助积分说明 809021